POM Investment Strategies’s Novo Nordisk NVO Stock Holding History

POM Investment Strategies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.8K	Hold	454	–	–	0.02%	134
2026 Q1	$16.7K	Hold	454	–	–	0.02%	173
2025 Q4	$23.1K	Sell	454 -40	-8%	-$2.04K	0.01%	107
2025 Q3	$27.4K	Hold	494	–	–	0.01%	74
2025 Q2	$34.1K	Hold	494	–	–	0.02%	52
2025 Q1	$34.3K	Hold	494	–	–	0.04%	61
2024 Q4	$42.5K	Hold	494	–	–	0.03%	84
2024 Q3	$58.8K	Buy	494 +40	+9%	+$5.33K	0.05%	63
2024 Q2	$64.8K	Hold	454	–	–	0.05%	65
2024 Q1	$58.3K	Hold	454	–	–	0.05%	63
2023 Q4	$47K	Buy	+454	New	+$44.9K	0.04%	60

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

POM Investment Strategies's NVO Position: Q2 2026 in Review

POM Investment Strategies held its Novo Nordisk (NVO) position steady in Q2 2026 at 454 shares worth $21.8K. The position accounts for 0.02% of the portfolio, ranked #134.

POM Investment Strategies first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $64.8K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

POM Investment Strategies held 454 shares of Novo Nordisk worth $21.8K as of Q2 2026.
POM Investment Strategies left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.02% of POM Investment Strategies's portfolio in Q2 2026, its #134 holding.
POM Investment Strategies first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
POM Investment Strategies's Novo Nordisk position peaked at $64.8K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.